|
Documentation, Procedural Shortfalls Spur Form 483 for Fresenius
Dialysis-drug maker Fresenius has been handed a Form 483 after an FDA inspection of its Ogden, Utah, facility raised concerns that post-sterilization visual inspections performed on solution bags may not be effective at catching leaks or contaminants.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives